DH agrees temporary price freeze with drug companies


The Department of Health has brokered a five-year deal with pharmaceutical companies that will bring in a fixed cap for the first time on the amount the NHS spends on branded medicines.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here